摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-methyl-4,7,10-tris(2-pyridylmethyl)-1,4,7,10-tetraazacyclododecane | 209550-40-3

中文名称
——
中文别名
——
英文名称
1-methyl-4,7,10-tris(2-pyridylmethyl)-1,4,7,10-tetraazacyclododecane
英文别名
1-Methyl-4,7,10-tris(pyridin-2-ylmethyl)-1,4,7,10-tetrazacyclododecane
1-methyl-4,7,10-tris(2-pyridylmethyl)-1,4,7,10-tetraazacyclododecane化学式
CAS
209550-40-3
化学式
C27H37N7
mdl
——
分子量
459.638
InChiKey
JOUYDRWOCUNGDQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    34
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    51.6
  • 氢给体数:
    0
  • 氢受体数:
    7

反应信息

  • 作为反应物:
    描述:
    manganese(II) perchlorate hexahydrate 、 1-methyl-4,7,10-tris(2-pyridylmethyl)-1,4,7,10-tetraazacyclododecane甲醇乙腈 为溶剂, 以48%的产率得到manganese(II)(1-methyl-4,7,10-tetrakis(2-pyridylmethyl)-1,4,7,10-tetraazacyclododecane)(ClO4)2
    参考文献:
    名称:
    Syntheses, crystal structures and properties of new manganese(II) complexes with macrocyclic polyamine ligands bearing pyridyl donor pendants
    摘要:
    Two new Mn-II complexes with polydentate macrocyclic polyamine ligands functionalized with pyridyl donor pendants, 1,4,7,10-tetrakis(2-pyridylmethyl)-1,4,7,10-tetraazacyclododecane (L-1) and 1-methly-4,7,10-tris(2-pyridylmethyl)-1,4,7, 10-tetraazacyclododecane (L-2), have been synthesized and their structures determined by X-ray diffraction analysis. In [MnL1](ClO4)(2) (I), the Mn-II central ion is eight-coordinated with all the eight donor nitrogens of L-1 (including four pendant pyridyl nitrogens and four tertiary amines of cyclen) to form a distorted square-prism coordination geometry, and in [MnL2](ClO4)(2) (II), the M-II central ion is seven-coordinated (distorted monocapped octahedral geometry) with all the seven nitrogen donor atoms of L2 (including three pendant pyridyl nitrogens and four tertiary amines of cyclen) comprising the donor set. The solution chemistry of the two Mn-II complexes has been further studied by cyclic voltammetry (CV), W-Vis and ESR spectral techniques. (C) 2000 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0277-5387(00)00510-6
点击查看最新优质反应信息

文献信息

  • Oxidative method
    申请人:Catexel Technologies Limited
    公开号:US10882745B2
    公开(公告)日:2021-01-05
    The present invention relates to a method of generating chlorine dioxide from chlorite salts in the presence of an iron ion-containing complex, a method of treating a substrate with a chlorine-containing oxidant in the presence of an iron ion-containing complex and related aqueous media, kits and compositions.
    本发明涉及一种在含离子络合物存在下从亚氯酸盐生成二氧化氯的方法、一种在含离子络合物存在下用含氧化剂处理基质的方法以及相关的介质、试剂盒和组合物。
  • The first seven-coordinated iron(II) complex with a nitrogen donor set hepta-dentate macrocyclic polyamine ligand and different coordination modes with its cobalt(II) analogue
    作者:Xian-He Bu、Wei Chen、Zhi-Hui Zhang、Ruo-Hua Zhang、Shan-Ming Kuang、Thomas Clifford
    DOI:10.1016/s0020-1693(00)00245-0
    日期:2000.12
    The Fe2+ and Co2+ complexes with a hepta-dentate ligand, 1-methyl-4,7,10-tris(2-pyridylmethyl)-1,4,7,10-tetraazacyclododecane (L), have been synthesized and their crystal structures determined by X-ray diffraction analyses. The two complexes have been found to have different coordination modes. The Fe2+ complex (I) is seven-coordinated with the four cyclen (cyclen = 1,4,7,10-tetraazacyclododecane) nitrogen donors and all three pendant pyridine nitrogens, adopting a mono-capped distorted octahedral coordination geometry. To our knowledge, this is the first example of a structurally characterized seven-coordinated Fe2+ complex formed with only one N-7 done; set ligand. Whereas the Co2+ complex (TI) of L is a normal six-coordination with four cyclen nitrogen donors and two pendant pyridines to give a distorted octahedron in which one pendant pyridine nitrogen remains uncoordinated. (C) 2000 Elsevier Science B.V. All rights reserved.
  • OXIDATIVE METHOD
    申请人:Catexel Technologies Limited
    公开号:EP3307941A1
    公开(公告)日:2018-04-18
  • US7399639B2
    申请人:——
    公开号:US7399639B2
    公开(公告)日:2008-07-15
  • US7488820B2
    申请人:——
    公开号:US7488820B2
    公开(公告)日:2009-02-10
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S,2'S)-(-)-[N,N'-双(2-吡啶基甲基]-2,2'-联吡咯烷双(乙腈)铁(II)六氟锑酸盐 (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 (1'R,2'S)-尼古丁1,1'-Di-N-氧化物 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸氯苯那敏-D6 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 韦德伊斯试剂 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非布索坦杂质66 非尼拉朵 非尼拉敏 雷索替丁 阿雷地平 阿瑞洛莫 阿扎那韦中间体 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 镉,二碘四(4-甲基吡啶)- 锌,二溴二[4-吡啶羧硫代酸(2-吡啶基亚甲基)酰肼]-